Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:41 UTC |
---|
HMDB ID | HMDB0014639 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Darifenacin |
---|
Description | Darifenacin, also known as enablex or emselex, belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. Darifenacin is a drug which is used for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Darifenacin is a very strong basic compound (based on its pKa). Darifenacin is a potentially toxic compound. |
---|
Structure | NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1 InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide | ChEBI | (S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-a,a-diphenyl-3-pyrrolidineacetamide | Generator | (S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-α,α-diphenyl-3-pyrrolidineacetamide | Generator | Enablex | HMDB | Darifenacin hydrochloride | HMDB | Darifenicin | HMDB | Darifenacin hydrobromide | HMDB | Emselex | HMDB | Darifenacine | HMDB |
|
---|
Chemical Formula | C28H30N2O2 |
---|
Average Molecular Weight | 426.55 |
---|
Monoisotopic Molecular Weight | 426.230728214 |
---|
IUPAC Name | 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide |
---|
Traditional Name | darifenacin |
---|
CAS Registry Number | 133099-04-4 |
---|
SMILES | NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1 |
---|
InChI Key | HXGBXQDTNZMWGS-RUZDIDTESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Diphenylmethanes |
---|
Direct Parent | Diphenylmethanes |
---|
Alternative Parents | |
---|
Substituents | - Diphenylmethane
- Phenylacetamide
- Phenethylamine
- Coumaran
- Alkyl aryl ether
- Aralkylamine
- N-alkylpyrrolidine
- Pyrrolidine
- Amino acid or derivatives
- Carboxamide group
- Primary carboxylic acid amide
- Tertiary amine
- Tertiary aliphatic amine
- Ether
- Carboxylic acid derivative
- Oxacycle
- Organoheterocyclic compound
- Azacycle
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Amine
- Carbonyl group
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0003 g/L | Not Available | LogP | 4.5 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Darifenacin,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1 | 3669.9 | Semi standard non polar | 33892256 | Darifenacin,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1 | 3317.7 | Standard non polar | 33892256 | Darifenacin,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1 | 4505.3 | Standard polar | 33892256 | Darifenacin,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)[Si](C)(C)C | 3694.3 | Semi standard non polar | 33892256 | Darifenacin,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)[Si](C)(C)C | 3479.4 | Standard non polar | 33892256 | Darifenacin,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)[Si](C)(C)C | 4331.1 | Standard polar | 33892256 | Darifenacin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1 | 3891.0 | Semi standard non polar | 33892256 | Darifenacin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1 | 3572.7 | Standard non polar | 33892256 | Darifenacin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1 | 4565.2 | Standard polar | 33892256 | Darifenacin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)[Si](C)(C)C(C)(C)C | 4129.2 | Semi standard non polar | 33892256 | Darifenacin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)[Si](C)(C)C(C)(C)C | 3877.8 | Standard non polar | 33892256 | Darifenacin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)[C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)[Si](C)(C)C(C)(C)C | 4368.9 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Darifenacin GC-MS (Non-derivatized) - 70eV, Positive | splash10-00lv-2491000000-40c43db64189724fe0c2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Darifenacin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 10V, Positive-QTOF | splash10-004i-0101900000-1979d23256753a983573 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 20V, Positive-QTOF | splash10-03gj-0756900000-6e69c78743e94527add2 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 40V, Positive-QTOF | splash10-0uxs-2910000000-ec1acf0e02b7c0a392f3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 10V, Negative-QTOF | splash10-004i-0001900000-e8c519b1d7f130de607a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 20V, Negative-QTOF | splash10-004i-4285900000-73144c3d58ba99d76581 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 40V, Negative-QTOF | splash10-0006-9030000000-5dfb7a1ae0753d3d4c11 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 10V, Negative-QTOF | splash10-005c-4005900000-8a58ca84e09117fd29e5 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 20V, Negative-QTOF | splash10-0006-9004100000-2c811675031a777fbc67 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 40V, Negative-QTOF | splash10-0006-9212000000-514c545cfeaf92ef3a8e | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 10V, Positive-QTOF | splash10-004i-0002900000-3905ca525d1dcc4e15f3 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 20V, Positive-QTOF | splash10-004i-0104900000-359dc4da59d626f0edf4 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Darifenacin 40V, Positive-QTOF | splash10-0002-0932000000-13b487199d725fb1e357 | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|